Nine ingredients to promote biosimilar and generics uptake
Though the utilization of biosimilars in Europe is high, a report on the practices of eight countries suggests that more can be done to foster competition and remove barriers to entry.
Archives for October 14, 2019
Life Image, Graticule tie-up aims to mature the industry’s use of advanced data
The goal of the partnership between Life Image and Graticule is to improve clinical trial results and accelerate drug development, while reducing costs, say company executives.
Lilly expands migraine offerings after FDA approval
US FDA gives marketing authorization to Lilly’s oral medication for the acute treatment of migraines in adult patients, adding to its Emgality approval almost exactly a year ago.
Alexion partners on Stealth’s late-stage mitochondrial asset
The two companies agree a co-development and commercialization agreement for elamipretide, which is in a Phase III trial for a mitochondrial disease.
Data deals: Parexel signs second RWD partnership this month
Parexel is incorporating real world data into ‘all aspects’ of clinical research via multi-year strategic partnership with Datavant.
GSK and AZ on continuous manufacturing platform ‘grand challenge’
A consortium between CPI and the University of Strathclyde aims to create a direct compression platform for continuous manufacturing of oral solid dosage drugs.
NSF acquires US-based CRO: ‘Companies urgently need solutions to problems’
With global health care ‘at a tipping point,’ NSF International expands its services across the product lifecycle with the acquisition of a US-headquartered CRO, says VP.